Phase
Condition
Menopause
Treatment
Placebo comparator
Mixture of (Poly)phenols and a probiotic supplement
Clinical Study ID
Ages 48-60 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults >48 years
Post-menopausal female subjects without clinical signs or symptoms of cardiovasculardisease, no menstruation cycle for more than 1 year, postmenopausal status conformedby female hormone analysis
For intervention purposes, eligible participants are also required to have a mobilephone and be able to read and speak English.
Exclusion
Exclusion Criteria:
• People with comorbid conditions that may limit participation in the study, such asa history of an acute cardiovascular event, uncontrolled hypertension, cancer ormajor psychiatric or cognitive problems
People who are already participating in a weight loss programme
People receiving drug treatment for lipid metabolisms (e.g., statins
People with a history of long-term use of medicines known to influence glucosemetabolism (e.g., corticosteroids)
People who take antibiotics or bacterial agents (Probiotics) within 1 month
Pregnant women, women ready for pregnancy, and nursing mothers
Post-menopausal female subjects without clinical signs or symptoms ofcardiovascular disease
acute inflammation
cardiac arrhythmia
renal failure
heart failure (NYHA II-IV)
diabetes mellitus
C-reactive protein > 0.5 mg/dL
malignant disease
hypotension (≤100 / 60 mm Hg)
Women who require hormone replacement therapy during the development of theprotocol.
Study Design
Study Description
Connect with a study center
Health Sciences Research Centre, Life Sciences Department, University of Roehampton
London, UK SW15 4JD
United KingdomActive - Recruiting
Adele Costabile
London, SW145JD
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.